微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 52.08% | 32.63% | -4.78% | 70/158 | -2.04% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 54.7% | 33.82% | 6.6% | 65/158 | 14.94% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 51.31% | 23.69% | 15.9% | 65/158 | 32.08% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 44.27% | -6.31% | 12.73% | 91/158 | 51.81% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 39.27% | -21.23% | -3.93% | 102/158 | 22.66% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 40.87% | -22.39% | -1.46% | 95/158 | 33.21% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 41.48% | -23.28% | -12.21% | 91/158 | 51.68% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 47.25% | 15.43% | -5.22% | 84/158 | 51.58% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 49.86% | 2% | -5.34% | 78/158 | 32.59% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 52.67% | 29.42% | -2.59% | 72/158 | 38.52% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 54.07% | 2% | 32.08% | 69/158 | 52.97% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 40.94% | -2.77% | 0.59% | 101/158 | 53.83% | 迈威生物 | 99.75% | 行业排名> |
| 2022-06-30 | 40.7% | -8.17% | -3.34% | 96/158 | 21.28% | 迈威生物 | 99.67% | 行业排名> |
| 2021-12-31 | 42.1% | -15.89% | -5% | 95/158 | 55.28% | 迈威生物 | 99.44% | 行业排名> |
| 2021-06-30 | 44.32% | -2.23% | -11.47% | 85/158 | 47.39% | 迈威生物 | 98.57% | 行业排名> |
| 2020-12-31 | 50.06% | 10.02% | 10.02% | 80/158 | -147.15% | 首药控股 | 99.93% | 行业排名> |
| 2019-12-31 | 45.5% | 23.4% | 0.38% | 88/158 | -1232.32% | 艾力斯 | 99.41% | 行业排名> |
| 2019-06-30 | 45.33% | 43.09% | 22.93% | 70/158 | 55.42% | 艾力斯 | 98.7% | 行业排名> |
| 2018-12-31 | 36.87% | 2% | 16.39% | 101/158 | -209.94% | 艾力斯 | 99.4% | 行业排名> |
| 2018-06-30 | 31.68% | 2% | 2% | 87/158 | 53.57% | 首药控股 | 99.94% | 行业排名> |